Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Abstract:  A formulation for preparing Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, dapsone, oral suspension, leprosy, pneumocystis pneumonia, dermatitis herpetiformis

Related Categories: DERMATOLOGY, FORMULATIONS, INFECTIOUS DISEASE, RESPIRATION/LUNG/BREATHING

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4388

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products